Vault-13

Seven Fleet Capital Management LP

MOUNTAIN VIEW, CA · CIK 2092021 · 13F filing filed 2026-08-17

SEC-registered investment adviser since 2026 · limited partnership

As an employer

$605.9m reported value +90.4% vs Q1 2026
96positions
65.1%in top 10
24 new 38 added 25 reduced 29 sold out vs Q1 2026

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CG ONCOLOGY INC COM CGON CGON 1,886,236 $134.0m22.12% 22.12% AddedShares held: Q3 2025 —, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.9m +371.1k +371,085 24.5%
2 TANGO THERAPEUTICS INC COM TNGX TNGX 3,228,144 $95.7m15.79% 15.79% AddedShares held: Q3 2025 —, Q4 2025 215.2k, Q1 2026 502.0k, Q2 2026 3.2m +2.7m +2,726,132 543.0%
3 REVOLUTION MEDICINES INC COM RVMD RVMD 242,029 $45.3m7.48% 7.48% AddedShares held: Q3 2025 —, Q4 2025 65.8k, Q1 2026 80.8k, Q2 2026 242.0k +161.2k +161,237 199.6%
4 PHARVARIS N V COM PHVS PHVS 774,501 $26.8m4.42% 4.42% AddedShares held: Q3 2025 —, Q4 2025 55.3k, Q1 2026 316.7k, Q2 2026 774.5k +457.8k +457,804 144.6%
5 LIQUIDIA CORPORATION COM NEW LQDA LQDA 256,603 $20.5m3.38% 3.38% AddedShares held: Q3 2025 —, Q4 2025 91.3k, Q1 2026 204.9k, Q2 2026 256.6k +51.7k +51,727 25.2%
6 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 365,386 $18.5m3.06% 3.06% AddedShares held: Q3 2025 —, Q4 2025 100.0k, Q1 2026 259.3k, Q2 2026 365.4k +106.1k +106,103 40.9%
7 ABIVAX SA SPONSORED ADS ABVX ABVX 111,334 $14.8m2.45% 2.45% AddedShares held: Q3 2025 —, Q4 2025 13.5k, Q1 2026 43.1k, Q2 2026 111.3k +68.3k +68,282 158.6%
8 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 770,765 $14.2m2.35% 2.35% AddedShares held: Q3 2025 —, Q4 2025 63.3k, Q1 2026 573.9k, Q2 2026 770.8k +196.9k +196,882 34.3%
9 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 110,393 $12.9m2.13% 2.13% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 110.4k
10 ASSEMBLY BIOSCIENCES INC COM NEW ASMB ASMB 433,147 $11.9m1.96% 1.96% AddedShares held: Q3 2025 —, Q4 2025 73.8k, Q1 2026 56.1k, Q2 2026 433.1k +377.0k +377,000 671.5%
11 CENTURY THERAPEUTICS INC COM IPSC IPSC 4,347,826 $10.7m1.76% 1.76% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 4.3m, Q2 2026 4.3m
12 CYTOKINETICS INC COM NEW CYTK CYTK 118,240 $10.1m1.66% 1.66% AddedShares held: Q3 2025 —, Q4 2025 10.3k, Q1 2026 61.3k, Q2 2026 118.2k +57.0k +56,971 93.0%
13 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 1,504,400 $9.9m1.64% 1.64% AddedShares held: Q3 2025 —, Q4 2025 167.2k, Q1 2026 625.7k, Q2 2026 1.5m +878.7k +878,692 140.4%
14 VERADERMICS INC COMMON STOCK MANE MANE 80,000 $9.8m1.62% 1.62% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 80.0k
15 ARRIVENT BIOPHARMA INC COM AVBP AVBP 246,606 $8.6m1.41% 1.41% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 50.3k, Q2 2026 246.6k +196.4k +196,354 390.7%
16 TARSUS PHARMACEUTICALS INC COM TARS TARS 117,067 $7.9m1.31% 1.31% AddedShares held: Q3 2025 —, Q4 2025 4.5k, Q1 2026 19.8k, Q2 2026 117.1k +97.3k +97,267 491.2%
17 XENCOR INC COM XNCR XNCR 368,305 $7.8m1.29% 1.29% AddedShares held: Q3 2025 —, Q4 2025 109.6k, Q1 2026 80.0k, Q2 2026 368.3k +288.3k +288,305 360.4%
18 ROIVANT SCIENCES LTD SHS ROIV ROIV 220,126 $7.8m1.29% 1.29% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 128.2k, Q2 2026 220.1k +92.0k +91,958 71.8%
19 DAMORA THERAPEUTICS INC COM NEW COM NEW 284,430 $7.4m1.22% 1.22% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 101.2k, Q2 2026 284.4k +183.2k +183,182 180.9%
20 AXSOME THERAPEUTICS INC COM AXSM AXSM 28,826 $7.1m1.16% 1.16% AddedShares held: Q3 2025 —, Q4 2025 13.0k, Q1 2026 14.1k, Q2 2026 28.8k +14.8k +14,771 105.1%
21 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 148,647 $7.0m1.15% 1.15% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 99.9k, Q2 2026 148.6k +48.8k +48,760 48.8%
22 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 64,723 $6.3m1.04% 1.04% ReducedShares held: Q3 2025 —, Q4 2025 14.7k, Q1 2026 80.8k, Q2 2026 64.7k -16.1k -16,086 -19.9%
23 COGENT BIOSCIENCES INC COM COGT COGT 147,510 $5.7m0.94% 0.94% ReducedShares held: Q3 2025 —, Q4 2025 214.1k, Q1 2026 149.4k, Q2 2026 147.5k -1.9k -1,889 -1.3%
24 ERASCA INC COM ERAS ERAS 308,007 $5.6m0.93% 0.93% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 222.5k, Q2 2026 308.0k +85.5k +85,539 38.5%
25 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 45,400 $5.6m0.92% 0.92% AddedShares held: Q3 2025 —, Q4 2025 8.0k, Q1 2026 4.0k, Q2 2026 45.4k +41.4k +41,400 1035.0%
26 MINERVA NEUROSCIENCES INC COM NEW NERV NERV 1,001,373 $5.6m0.92% 0.92% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.0m -136.4k -136,357 -12.0%
27 EDITAS MEDICINE INC COM EDIT EDIT 1,330,500 $4.3m0.71% 0.71% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.3m
28 CYTOMX THERAPEUTICS INC COM CTMX CTMX 1,085,398 $4.1m0.67% 0.67% UnchangedShares held: Q3 2025 —, Q4 2025 48.9k, Q1 2026 1.1m, Q2 2026 1.1m
29 EUPRAXIA PHARMACEUTICALS INC COM EPRX EPRX 610,785 $4.0m0.67% 0.67% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 709.5k, Q2 2026 610.8k -98.7k -98,730 -13.9%
30 SUTRO BIOPHARMA INC COM SHS STRO STRO 159,118 $3.8m0.63% 0.63% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 159.1k
31 RELAY THERAPEUTICS INC COM RLAY RLAY 178,222 $3.3m0.55% 0.55% ReducedShares held: Q3 2025 —, Q4 2025 73.0k, Q1 2026 257.7k, Q2 2026 178.2k -79.5k -79,516 -30.9%
32 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 86,664 $3.2m0.53% 0.53% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 29.3k, Q2 2026 86.7k +57.4k +57,364 195.8%
33 ASCENDIS PHARMA A/S ORD SHS ASND ASND 11,869 $3.2m0.52% 0.52% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 11.9k
34 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 403,545 $3.1m0.51% 0.51% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 403.5k
35 ZAI LAB LTD ADR ZLAB ZLAB 136,016 $2.9m0.48% 0.48% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 77.9k, Q2 2026 136.0k +58.2k +58,158 74.7%
36 SAB BIOTHERAPEUTICS INC COM NEW SABS SABS 736,077 $2.9m0.47% 0.47% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 500.0k, Q2 2026 736.1k +236.1k +236,077 47.2%
37 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 4,973 $2.7m0.44% 0.44% AddedShares held: Q3 2025 —, Q4 2025 1.9k, Q1 2026 3.4k, Q2 2026 5.0k +1.6k +1,580 46.6%
38 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 7,540 $2.5m0.42% 0.42% NewShares held: Q3 2025 —, Q4 2025 2.7k, Q1 2026 0, Q2 2026 7.5k
39 RELMADA THERAPEUTICS INC COM RLMD RLMD 348,265 $2.4m0.40% 0.40% NewShares held: Q3 2025 —, Q4 2025 154.1k, Q1 2026 0, Q2 2026 348.3k
40 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 56,900 $2.1m0.35% 0.35% ReducedShares held: Q3 2025 —, Q4 2025 31.7k, Q1 2026 209.5k, Q2 2026 56.9k -152.6k -152,647 -72.8%
41 XENON PHARMACEUTICALS INC COM XENE XENE 33,300 $2.1m0.34% 0.34% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 33.3k
42 SAVARA INC COM SVRA SVRA 309,103 $1.9m0.31% 0.31% AddedShares held: Q3 2025 —, Q4 2025 62.8k, Q1 2026 295.7k, Q2 2026 309.1k +13.4k +13,415 4.5%
43 C4 THERAPEUTICS INC COM STK CCCC CCCC 381,169 $1.8m0.29% 0.29% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 57.1k, Q2 2026 381.2k +324.1k +324,093 567.8%
44 VAXCYTE INC COM PCVX PCVX 29,800 $1.8m0.29% 0.29% ReducedShares held: Q3 2025 —, Q4 2025 25.4k, Q1 2026 128.4k, Q2 2026 29.8k -98.7k -98,650 -76.8%
45 CELCUITY INC COM CELC CELC 16,252 $1.7m0.28% 0.28% AddedShares held: Q3 2025 —, Q4 2025 8.3k, Q1 2026 6.0k, Q2 2026 16.3k +10.3k +10,252 170.9%
46 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 77,930 $1.6m0.27% 0.27% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 77.9k
47 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 317,600 $1.5m0.24% 0.24% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 110.0k, Q2 2026 317.6k +207.6k +207,600 188.7%
48 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 26,800 $1.4m0.24% 0.24% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 9.0k, Q2 2026 26.8k +17.8k +17,800 197.8%
49 LEONABIO INC COM LONA LONA 154,153 $1.4m0.23% 0.23% ReducedShares held: Q3 2025 —, Q4 2025 128.0k, Q1 2026 164.7k, Q2 2026 154.2k -10.5k -10,523 -6.4%
50 IDEAYA BIOSCIENCES INC COM IDYA IDYA 37,865 $1.4m0.23% 0.23% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 86.3k, Q2 2026 37.9k -48.4k -48,418 -56.1%
51 GERON CORP COM GERN GERN 1,057,228 $1.4m0.22% 0.22% AddedShares held: Q3 2025 —, Q4 2025 777.9k, Q1 2026 424.2k, Q2 2026 1.1m +633.0k +633,048 149.2%
52 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 113,207 $1.3m0.21% 0.21% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 113.2k
53 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 82,890 $1.2m0.20% 0.20% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 82.9k, Q2 2026 82.9k
54 ALKERMES PLC SHS ALKS ALKS 23,285 $1.2m0.20% 0.20% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 24.2k, Q2 2026 23.3k -885 -885 -3.7%
55 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 13,300 $1.2m0.19% 0.19% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 19.7k, Q2 2026 13.3k -6.4k -6,390 -32.5%
56 PERSPECTIVE THERAPEUTICS INC COM NEW CATX CATX 332,613 $1.1m0.19% 0.19% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 379.1k, Q2 2026 332.6k -46.5k -46,469 -12.3%
57 ONKURE THERAPEUTICS INC COM CL A OKUR OKUR 240,963 $1.1m0.18% 0.18% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 241.0k
58 SUMMIT THERAPEUTICS INC COM SMMT SMMT 73,300 $1.1m0.18% 0.18% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 73.3k
59 AN2 THERAPEUTICS INC COM ANTX ANTX 208,946 $1.0m0.17% 0.17% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 199.7k, Q2 2026 208.9k +9.2k +9,245 4.6%
60 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 60,541 $992.3k0.16% 0.16% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 27.1k, Q2 2026 60.5k +33.5k +33,487 123.8%
61 TREVI THERAPEUTICS INC COM TRVI TRVI 45,598 $833.4k0.14% 0.14% AddedShares held: Q3 2025 —, Q4 2025 7.1k, Q1 2026 27.1k, Q2 2026 45.6k +18.4k +18,449 68.0%
62 VOYAGER THERAPEUTICS INC COM VYGR VYGR 230,406 $771.9k0.13% 0.13% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 115.2k, Q2 2026 230.4k +115.2k +115,203 100.0%
63 INVENTIVA SA ADS IVA IVA 200,141 $756.5k0.12% 0.12% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 200.1k, Q2 2026 200.1k
64 ENGENE THERAPEUTICS INC COM ENGN ENGN 411,065 $711.1k0.12% 0.12% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 411.1k
65 LARIMAR THERAPEUTICS INC COM LRMR LRMR 230,921 $704.3k0.12% 0.12% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 256.6k, Q2 2026 230.9k -25.7k -25,664 -10.0%
66 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 346,900 $704.2k0.12% 0.12% AddedShares held: Q3 2025 —, Q4 2025 533.6k, Q1 2026 325.6k, Q2 2026 346.9k +21.3k +21,300 6.5%
67 NEUROGENE INC COM NGNE NGNE 22,060 $693.8k0.11% 0.11% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 22.1k
68 ISHARES TR U.S. MED DVC ETF IHI IHI 13,800 $681.9k0.11% 0.11% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 13.8k
69 SILENCE THERAPEUTICS PLC ADS SLN SLN 60,107 $660.0k0.11% 0.11% ReducedShares held: Q3 2025 —, Q4 2025 147.6k, Q1 2026 156.8k, Q2 2026 60.1k -96.7k -96,652 -61.7%
70 KRYSTAL BIOTECH INC COM KRYS KRYS 1,774 $659.3k0.11% 0.11% ReducedShares held: Q3 2025 —, Q4 2025 4.0k, Q1 2026 4.3k, Q2 2026 1.8k -2.5k -2,542 -58.9%
71 OPUS GENETICS INC COM IRD IRD 143,137 $588.3k0.10% 0.10% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 134.2k, Q2 2026 143.1k +8.9k +8,895 6.6%
72 PALISADE BIO INC COM PALI PALI 272,204 $568.9k0.09% 0.09% AddedShares held: Q3 2025 —, Q4 2025 327.5k, Q1 2026 213.1k, Q2 2026 272.2k +59.1k +59,104 27.7%
73 EVOLUS INC COM EOLS EOLS 78,057 $541.7k0.09% 0.09% UnchangedShares held: Q3 2025 —, Q4 2025 82.0k, Q1 2026 78.1k, Q2 2026 78.1k
74 UNICYCIVE THERAPEUTICS INC COM NEW UNCY UNCY 103,400 $521.1k0.09% 0.09% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 55.7k, Q2 2026 103.4k +47.7k +47,700 85.6%
75 COMPASS THERAPEUTICS INC COM CMPX CMPX 233,066 $510.4k0.08% 0.08% ReducedShares held: Q3 2025 —, Q4 2025 568.7k, Q1 2026 940.5k, Q2 2026 233.1k -707.5k -707,472 -75.2%
76 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 51,024 $510.2k0.08% 0.08% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 102.5k, Q2 2026 51.0k -51.5k -51,469 -50.2%
77 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 6,395 $448.9k0.07% 0.07% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 6.4k, Q2 2026 6.4k
78 PROTHENA CORP PLC SHS PRTA PRTA 43,300 $423.9k0.07% 0.07% UnchangedShares held: Q3 2025 —, Q4 2025 43.3k, Q1 2026 43.3k, Q2 2026 43.3k
79 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 16,800 $406.6k0.07% 0.07% ReducedShares held: Q3 2025 —, Q4 2025 4.0k, Q1 2026 22.5k, Q2 2026 16.8k -5.7k -5,730 -25.4%
80 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 31,476 $393.8k0.06% 0.06% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 31.5k
81 MILESTONE PHARMACEUTICALS IN COM MIST MIST 270,233 $362.1k0.06% 0.06% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 333.3k, Q2 2026 270.2k -63.1k -63,100 -18.9%
82 ENTERA BIO LTD SHS ENTX ENTX 191,354 $338.7k0.06% 0.06% ReducedShares held: Q3 2025 —, Q4 2025 135.3k, Q1 2026 205.5k, Q2 2026 191.4k -14.2k -14,188 -6.9%
83 CUE BIOPHARMA INC COM CUE CUE 10,702 $337.8k0.06% 0.06% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 10.7k
84 MBX BIOSCIENCES INC COM MBX MBX 6,000 $331.2k0.05% 0.05% NewShares held: Q3 2025 —, Q4 2025 18.2k, Q1 2026 0, Q2 2026 6.0k
85 BEAM THERAPEUTICS INC COM BEAM BEAM 8,804 $302.2k0.05% 0.05% UnchangedShares held: Q3 2025 —, Q4 2025 9.5k, Q1 2026 8.8k, Q2 2026 8.8k
86 ASTRAZENECA PLC ORD AZN AZN 1,400 $265.5k0.04% 0.04% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 1.4k
87 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 14,540 $261.1k0.04% 0.04% ReducedShares held: Q3 2025 —, Q4 2025 11.6k, Q1 2026 16.7k, Q2 2026 14.5k -2.1k -2,131 -12.8%
88 STOKE THERAPEUTICS INC COM STOK STOK 7,745 $255.4k0.04% 0.04% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 7.7k
89 VIKING THERAPEUTICS INC COM VKTX VKTX 7,404 $251.9k0.04% 0.04% NewShares held: Q3 2025 —, Q4 2025 6.0k, Q1 2026 0, Q2 2026 7.4k
90 LIPOCINE INC NEW COM NEW LPCN LPCN 78,842 $201.8k0.03% 0.03% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 124.9k, Q2 2026 78.8k -46.1k -46,100 -36.9%
91 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 21,432 $201.0k0.03% 0.03% ReducedShares held: Q3 2025 —, Q4 2025 56.8k, Q1 2026 85.7k, Q2 2026 21.4k -64.3k -64,255 -75.0%
92 PROMIS NEUROSCIENCES INC COM SHS PMN PMN 10,600 $139.5k0.02% 0.02% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 10.6k, Q2 2026 10.6k
93 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 19,048 $99.8k0.02% 0.02% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 19.0k
94 PMV PHARMACEUTICALS INC COM PMVP PMVP 53,569 $71.8k0.01% 0.01% ReducedShares held: Q3 2025 —, Q4 2025 63.5k, Q1 2026 63.5k, Q2 2026 53.6k -9.9k -9,929 -15.6%
95 FULCRUM THERAPEUTICS INC COM FULC FULC 18,089 $66.2k0.01% 0.01% ReducedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 38.1k, Q2 2026 18.1k -20.0k -20,011 -52.5%
96 UNIQURE NV SHS QURE QURE 338 $15.3k0.00% 0.00% NewShares held: Q3 2025 —, Q4 2025 8.7k, Q1 2026 0, Q2 2026 338

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
TYRA BIOSCIENCES INC TYRA TYRA 198,585 $7.6m198.6k shares
TANGO THERAPEUTICS INC 300,648 $6.3m300.6k shares
SOLENO THERAPEUTICS INC SLNO SLNO 115,770 $3.9m115.8k shares
ASCENDIS PHARMA A/S 12,179 $2.8m12.2k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 128,487 $2.6m128.5k shares
MINERALYS THERAPEUTICS INC MLYS MLYS 69,571 $1.9m69.6k shares
SOLENO THERAPEUTICS INC 54,000 $1.8m54.0k shares
REPLIMUNE GROUP INC REPL REPL 120,400 $921.1k120.4k shares
MAZE THERAPEUTICS INC MAZE MAZE 30,707 $916.6k30.7k shares
CLIMB BIO INC CLYM CLYM 130,654 $895.0k130.7k shares
COMPASS PATHWAYS PLC CMPS CMPS 158,021 $873.9k158.0k shares
DENALI THERAPEUTICS INC DNLI DNLI 35,286 $677.5k35.3k shares
UNITED THERAPEUTICS CORP DEL UTHR UTHR 1,128 $668.9k1.1k shares
ELI LILLY & CO LLY LLY 720 $662.2k720 shares
VERASTEM INC VSTM VSTM 123,400 $654.0k123.4k shares
CONTEXT THERAPEUTICS INC CNTX CNTX 190,785 $499.9k190.8k shares
INTELLIA THERAPEUTICS INC NTLA NTLA 31,500 $403.8k31.5k shares
EDGEWISE THERAPEUTICS INC EWTX EWTX 11,701 $368.6k11.7k shares
NEKTAR THERAPEUTICS NKTR NKTR 4,300 $309.4k4.3k shares
SEPTERNA INC SEPN SEPN 11,445 $275.0k11.4k shares
OCULAR THERAPEUTIX INC OCUL OCUL 31,296 $265.1k31.3k shares
NUVALENT INC 2,072 $212.3k2.1k shares
DISC MEDICINE INC IRON IRON 3,231 $206.6k3.2k shares
AADI BIOSCIENCE INC WHWK WHWK 54,296 $187.3k54.3k shares
INHIBRX BIOSCIENCES INC INBX INBX 2,482 $166.9k2.5k shares